Irritable bowel syndrome (IBS) is a common disorder characterized by recurrent abdominal pain and altered bowel habits, often accompanied by bloating.1,2 IBS is classified according to the predominant bowel symptom as IBS with constipation (IBS-C), IBS with diarrhea (IBS-D), mixed type (IBS-M), or unclassified (IBS-U). Alterations in the microbiome, stress responses, sensory and motor function of the gut, and host genetic factors may be contributing factors. Since the exact cause of IBS is unknown, the goal of treatment is symptom control.

Continue reading

More from Issue 1594
Previous Issue: 1593      March 9, 2020
Coming Soon
Trijardy XR - A Combination of 3 Old Drugs for Type 2 Diabetes
Bempedoic Acid (Nexletol) for Lowering LDL-Cholesterol
Cefiderocol (Fetroja) for Complicated Urinary Tract Infections
Follow us   Twitter LinkedIn YouTube Blog RSS   Email Alerts
Advance Release
The rapid spread and severity of COVID-19 (caused by SARS-CoV-2) have raised some questions about use of various drugs in patients with the disease and whether currently available drugs could be effective in treating it. Definitive answers are lacking, but some recommendations can be made. Updated information on COVID-19 is available from the CDC at www.cdc. ... Continue reading